BioVaxys Technology (BioVaxys Technology) Market Cap : $7.86 Mil (As of May. 06, 2024)

View and export this data going back to 2018. Start your Free Trial

What is BioVaxys Technology Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). BioVaxys Technology's share price for the quarter that ended in Jul. 2023 was $0.0156. BioVaxys Technology's Shares Outstanding (EOP) for the quarter that ended in Jul. 2023 was 145.11 Mil. Therefore, BioVaxys Technology's market cap for the quarter that ended in Jul. 2023 was $2.26 Mil.

BioVaxys Technology's quarterly market cap declined from Jan. 2023 ($8.81 Mil) to Apr. 2023 ($4.44 Mil) and declined from Apr. 2023 ($4.44 Mil) to Jul. 2023 ($2.26 Mil).

BioVaxys Technology's annual market cap increased from Oct. 2020 ($23.16 Mil) to Oct. 2021 ($27.66 Mil) but then declined from Oct. 2021 ($27.66 Mil) to Oct. 2022 ($16.57 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. BioVaxys Technology's Enterprise Value for Today is $8.49 Mil.

BioVaxys Technology Market Cap Historical Data

The historical data trend for BioVaxys Technology's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioVaxys Technology Market Cap Chart

BioVaxys Technology Annual Data

Trend

Oct18

Oct19

Oct20

Oct21

Oct22

Market Cap

1.29

23.16

27.66

16.57

BioVaxys Technology Quarterly Data
	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23
Market Cap	Get a 7-Day Free Trial															10.70	16.57	8.81	4.44	2.26

Competitive Comparison of BioVaxys Technology's Market Cap

For the Biotechnology subindustry, BioVaxys Technology's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioVaxys Technology's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioVaxys Technology's Market Cap distribution charts can be found below:

* The bar in red indicates where BioVaxys Technology's Market Cap falls into.

BioVaxys Technology Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

BioVaxys Technology's Market Cap for the fiscal year that ended in Oct. 2022 is calculated as

Market Cap (A: Oct. 2022 )	=	Share Price (A: Oct. 2022 )	*	Shares Outstanding (EOP) (A: Oct. 2022 )
	=	$0.1523	*	108.813
	=	$16.57

BioVaxys Technology's Market Cap for the quarter that ended in Jul. 2023 is calculated as

Market Cap (Q: Jul. 2023 )	=	Share Price (Q: Jul. 2023 )	*	Shares Outstanding (EOP) (Q: Jul. 2023 )
	=	$0.0156	*	145.112
	=	$2.26

BioVaxys Technology (OTCPK:BVAXF) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

BioVaxys Technology Market Cap Related Terms

Thank you for viewing the detailed overview of BioVaxys Technology's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

BioVaxys Technology (BioVaxys Technology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioVaxys Technology Corp (OTCPK:BVAXF) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

5LB:Germany BIOV:Canada

Address

146 Thirtieth Street, Suite 100, Etobicoke, ON, CAN, M8W 3D4

Website

https://www.biovaxys.com

BioVaxys Technology Corp is a clinical-stage biopharma company. The company develops antiviral and anticancer vaccine platforms to treat SARS-CoV-2 and other viral infections, as well as ovarian cancer and other solid tumor types.